SMP-3124LP

N/A

Report date: 2024/08/06 20:00:05
NME

Base Information

Drug NameSMP-3124LP
Drug Alias NameSMP3124LPSMP-3124LP
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCheckpoint kinase 1 inhibitors
TargetsCheckpoint kinase 1
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesJapan
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesSumitomo Chemical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSumitomo Pharma America Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A